Results 11 to 20 of about 2,219,611 (304)
Arthritis Research & Therapy, 2022 Background The objective of this study was to investigate the prognostic impact of right ventricular (RV) function at rest and during exercise in patients with systemic sclerosis (SSc) presenting for a screening for pulmonary hypertension (PH).
Panagiota Xanthouli +11 more
doaj +1 more source
Scientific Reports, 2023 Oxygenated hemoglobin (OxyHem) in arterial blood may reflect disease severity in patients with systemic sclerosis (SSc). The aim of this study was to analyze the predictive value of OxyHem in SSc patients screened for pulmonary hypertension (PH). OxyHem (
Panagiota Xanthouli +12 more
doaj +1 more source
Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
International Journal of Environmental Research and Public Health, 2021 Alveolar hypoxia is the most prominent feature of high altitude environment with well-known consequences for the cardio-pulmonary system, including development of pulmonary hypertension.
A. Sydykov +7 more
semanticscholar +1 more source
Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
Respiratory Research, 2021 Background Iron deficiency affects up to 50% of patients with pulmonary arterial hypertension (PAH) but iron markers such as ferritin and serum iron are confounded by several non-disease related factors like acute inflammation and diet.
Panagiota Xanthouli +13 more
doaj +1 more source
The physiological basis of pulmonary arterial hypertension
European Respiratory Journal, 2021 Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) failure.
R. Naeije, M. Richter, L. Rubin
semanticscholar +1 more source
Canadian Journal of Cardiology, 2010 Abstract Symptoms of unexplained exertional breathlessness or symptoms out of proportion to coexistent heart or lung disease should alert the clinician to the possibility of pulmonary hypertension, and the condition should be actively sought in patients with known associated conditions, such as scleroderma, hypoxic lung disease, liver ...
Benjamin, Hibbert +4 more
openaire +3 more sources
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
European Respiratory Journal, 2019 Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal
G. Simonneau +7 more
semanticscholar +1 more source
ERS statement on chronic thromboembolic pulmonary hypertension
European Respiratory Journal, 2020 Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries by fibrotic intravascular material, in combination with a secondary ...
M. Delcroix +28 more
semanticscholar +1 more source
, 2011 The fundamental morphologic classification into plexogenic arteriopathy, thromboembolic pulmonary hypertension, pulmonary venous hypertension, and pulmonary hypertension associated with intrinsic lung disease and/or hypoxia, remains similar to the previous edition, but pulmonary capillary hemangiomatosis (PCH) is now viewed as a part of pulmonary ...
Andrew M. Churg, Joanne L. Wright
openaire +4 more sources
American Journal of Respiratory and Critical Care Medicine, 2005 The modern era in cardiopulmonary medicine began in the 1940s, when Cournand and Richards pioneered right-heart catheterization. Until that time, no direct measurement of central vascular pressure had been performed in humans. Right-heart catheterization ignited an explosion of insights into function and dysfunction of the pulmonary circulation ...
Paul, McLoughlin +2 more
openaire +4 more sources